— Know what they know.
Not Investment Advice

ZVSA OTC

ZyVersa Therapeutics, Inc.
1W: -19.2% 1M: -19.4% 3M: -48.1% YTD: -40.7% 1Y: -44.1% 3Y: -99.8%
$0.08
+0.00 (+0.00%)
 
Weekly Expected Move ±16.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $647674 mcap · 5M float · 0.217% daily turnover · Short 31% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-100.0% YoY
$-24M
Net Income
-176.9% YoY
$-4,141M
Free Cash Flow
+14.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE817.1%
ROA-6.4%
ROIC242.0%

Valuation

P/E-0.0
P/B-45.9
EV/EBITDA-101.9

Leverage

Debt/Equity-84.96
Current Ratio0.05
Interest Cov.-46.9x

Quality Scores

Piotroski F1/9
Altman Z-23.14
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms